| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1040643514 |
| P356 | DOI | 10.1186/S13293-016-0085-7 |
| P8608 | Fatcat ID | release_i6h5ixcgo5a2hmjatoqegasb5m |
| P3181 | OpenCitations bibliographic resource ID | 4741289 |
| P932 | PMC publication ID | 4924261 |
| P698 | PubMed publication ID | 27354902 |
| P2093 | author name string | David A Hart | |
| P2860 | cites work | Social isolation during puberty affects female sexual behavior in mice | Q21131046 |
| Therapeutic targeting of macrophages in lupus nephritis | Q26796277 | ||
| Lupus nephritis: the evolving role of novel therapeutics | Q26998390 | ||
| Lithium salts in the treatment of psychotic excitement | Q28262417 | ||
| Sex differences in patients with systemic lupus erythematosus from Northwest Spain. | Q33408763 | ||
| Copy number variants in genetic susceptibility and severity of systemic lupus erythematosus | Q33680420 | ||
| Comparative effects of n-3, n-6 and n-9 unsaturated fatty acid-rich diet consumption on lupus nephritis, autoantibody production and CD4+ T cell-related gene responses in the autoimmune NZBWF1 mouse | Q33778956 | ||
| Lupus: why women? | Q34271916 | ||
| The melanocortin-1 receptor: red hair and beyond | Q34439350 | ||
| Agouti: from mouse to man, from skin to fat. | Q34523557 | ||
| Urokinase and its receptors in chronic kidney disease. | Q35124141 | ||
| An exploratory study of responses to low-dose lithium in African Americans and Hispanics. | Q35428586 | ||
| Impact of dietary deviation on disease progression and gut microbiome composition in lupus-prone SNF1 mice. | Q35565080 | ||
| The candidate gene approach: have murine models informed the study of human SLE? | Q35804473 | ||
| The metabolic syndrome as a risk factor for chronic kidney disease: more than a fat chance? | Q35927739 | ||
| Gender differences in the pathogenesis and outcome of lupus and of lupus nephritis | Q36011552 | ||
| Cutaneous manifestations of systemic lupus erythematosus. | Q36134951 | ||
| Retroviral gp70 immune complexes in NZB x NZW F2 mice with murine lupus nephritis | Q36345458 | ||
| Mouse coat color mutations: from fancy mice to functional genomics | Q36476144 | ||
| Incidence of End-Stage Renal Disease Among Newly Diagnosed Systemic Lupus Erythematosus Patients: The Georgia Lupus Registry | Q36540787 | ||
| A role for sex chromosome complement in the female bias in autoimmune disease | Q36639999 | ||
| Genetics of human lupus nephritis | Q36750925 | ||
| Differential regulation of STAT family members by glycogen synthase kinase-3 | Q36808508 | ||
| Lithium: a versatile tool for understanding renal physiology. | Q36836247 | ||
| The frequency and outcome of lupus nephritis: results from an international inception cohort study | Q37082037 | ||
| Estrogen receptors in the kidney: lessons from genetically altered mice | Q37131806 | ||
| Beta-catenin in the race to fracture repair: in it to Wnt. | Q37193616 | ||
| European genetic ancestry is associated with a decreased risk of lupus nephritis | Q37398821 | ||
| New directions in the treatment of systemic lupus erythematosus | Q37478595 | ||
| Sites of urokinase-type plasminogen activator expression and distribution of its receptor in the normal human kidney | Q71575223 | ||
| Lithium-responsive affective disorders: no association with the tyrosine hydroxylase gene | Q71767747 | ||
| Decreased pro-inflammatory cytokines and increased antioxidant enzyme gene expression by omega-3 lipids in murine lupus nephritis | Q72412312 | ||
| Calorie restriction decreases proinflammatory cytokines and polymeric Ig receptor expression in the submandibular glands of autoimmune prone (NZB x NZW)F1 mice | Q73122550 | ||
| Point mutations in the melanocortin-4 receptor cause variable obesity in mice | Q79401864 | ||
| Association of metabolic syndrome in nondiabetic patients with increased risk for chronic kidney disease: the fat lady sings | Q81827435 | ||
| Murine lupus strains differentially model unique facets of human lupus serology | Q83797566 | ||
| Lithium: updated human knowledge using an evidence-based approach: part III: clinical safety | Q37488179 | ||
| Obesity, hypertension, and chronic kidney disease | Q37601245 | ||
| Leveraging melanocortin pathways to treat glomerular diseases | Q37632054 | ||
| Diagnostic use of autoantibodies in myasthenia gravis | Q37727987 | ||
| End-stage renal disease in African Americans with lupus nephritis is associated with APOL1 | Q37728822 | ||
| Diet and nutritional aspects in systemic lupus erythematosus. | Q38014011 | ||
| B-cell depletion in the treatment of lupus nephritis | Q38026784 | ||
| Asian ethnicity in systemic lupus erythematosus: an Australian perspective. | Q38070903 | ||
| Sexual disparities in the incidence and course of SLE and RA. | Q38098331 | ||
| Family of melanocortin receptor (MCR) genes in mammals-mutations, polymorphisms and phenotypic effects | Q38133424 | ||
| Renoprotective strategies in lupus nephritis: beyond immunosuppression. | Q38149854 | ||
| Weight considerations in psychotropic drug prescribing and switching | Q38151453 | ||
| Anti-B cell antibody therapies for inflammatory rheumatic diseases | Q38155645 | ||
| T cell subsets and their role in the pathogenesis of rheumatic disease | Q38180303 | ||
| Obesity in autoimmune diseases: not a passive bystander | Q38237025 | ||
| Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis | Q38396871 | ||
| Towards new avenues in the management of lupus glomerulonephritis | Q38686467 | ||
| Poor prognostic factors of lupus nephritis | Q39118200 | ||
| Alpha-melanocyte stimulating hormone ameliorates disease activity in an induced murine lupus-like model | Q39223279 | ||
| Natural history of murine lupus. Modulation by sex hormones | Q39737795 | ||
| Distinct roles for AF-1 and -2 of ER-alpha in regulation of MMP-13 promoter activity | Q39888725 | ||
| Inhibition of G Protein βγ Subunit Signaling Abrogates Nephritis in Lupus-Prone Mice | Q39909362 | ||
| Polymorphisms in the promoter regions for human MMP-1 and MMP-13 lead to differential responses to the alpha and beta isoforms of estrogen receptor and their ligand in vitro | Q39999739 | ||
| Etiopathogenesis of Murine SLE1 | Q40100402 | ||
| Autoimmunity and the immunologic network | Q40176919 | ||
| Activation by lithium ions of the inside sodium sites in (Na+ + K+)-ATPase | Q40196218 | ||
| Estrogen receptor alpha regulates matrix metalloproteinase-13 promoter activity primarily through the AP-1 transcriptional regulatory site | Q40241988 | ||
| Sex hormones and modulation of immune response in SLE. | Q40242808 | ||
| Strain differences in lithium attenuation of d-amphetamine-induced hyperlocomotion: a mouse model for the genetics of clinical response to lithium | Q40262756 | ||
| Hepatocyte growth factor suppresses acute renal inflammation by inhibition of endothelial E-selectin | Q40311490 | ||
| Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis | Q43989009 | ||
| Partial characterization of the enhanced survival of female NZB/W mice treated with lithium chloride | Q44681842 | ||
| Lithium treatment inhibits renal GSK-3 activity and promotes cyclooxygenase 2-dependent polyuria | Q45178530 | ||
| Altered expression of selected genes in kidney of rats with lithium-induced NDI. | Q45248562 | ||
| A soy diet accelerates renal damage in autoimmune MRL/Mp-lpr/lpr mice | Q46615012 | ||
| Systemic lupus erythematosus onset in lupus-prone B6.MRL/lpr mice Is influenced by weight gain and Is preceded by an increase in neutrophil oxidative burst activity. | Q46708709 | ||
| Lithium preferentially inhibits adenylyl cyclase V and VII isoforms | Q46800574 | ||
| alpha-Melanocyte-stimulating hormone and acute renal failure | Q47742800 | ||
| Gender differences are associated with the clinical features of systemic lupus erythematosus. | Q50920535 | ||
| Worse renal outcome of lupus nephritis in male patients: a case-control study. | Q51490837 | ||
| Porcine proximal tubular cells (LLC-PK1) are able to tolerate high levels of lithium chloride in vitro: assessment of the influence of 1-20 mM LiCl on cell death and alterations in cell biology and biochemistry. | Q53357417 | ||
| Murine models of systemic lupus erythematosus | Q69894910 | ||
| Lithium chloride enhances survival of NZB/W lupus mice: influence of melatonin and timing of treatment | Q70964251 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lifetime | Q22675021 |
| P304 | page(s) | 31 | |
| P577 | publication date | 2016-01-01 | |
| P1433 | published in | Biology of Sex Differences | Q27723474 |
| P1476 | title | Sex-specific effects of LiCl treatment on preservation of renal function and extended life-span in murine models of SLE: perspective on insights into the potential basis for survivorship in NZB/W female mice | |
| P478 | volume | 7 |
Search more.